Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
You've successfully got advanced quotes worth 5000 HKD
Download APP >>

Short Interest in BetterLife Pharma Inc. (OTCMKTS:BETRF) Declines By 20.5%

Defense World ·  {{timeTz}}

BetterLife Pharma Inc. (OTCMKTS:BETRF – Get Rating) saw a large drop in short interest in the month of July. As of July 15th, there was short interest totalling 57,100 shares, a drop of 20.5% from the June 30th total of 71,800 shares. Based on an average trading volume of 47,100 shares, the days-to-cover ratio is currently 1.2 days.

BetterLife Pharma Price Performance

OTCMKTS BETRF opened at $0.11 on Thursday. The company has a market cap of $5.52 million, a P/E ratio of -0.89 and a beta of 2.90. The stock has a 50-day moving average of $0.09 and a two-hundred day moving average of $0.11. BetterLife Pharma has a 1-year low of $0.05 and a 1-year high of $0.30.

Get BetterLife Pharma alerts:

BetterLife Pharma (OTCMKTS:BETRF – Get Rating) last posted its quarterly earnings data on Tuesday, June 28th. The company reported ($0.03) EPS for the quarter.

About BetterLife Pharma

(Get Rating)

BetterLife Pharma Inc, a biotechnology company, engages in the development and commercialization of compounds for the treatment of neurological disorders in Canada and internationally. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections.

Further Reading

  • Get a free copy of the research report on BetterLife Pharma (BETRF)
  • There Are Different Types of Stock To Invest In
  • Is it Time to Tap Molson Coors or Will Beer Sales Turn Flat?
  • PayPal Continues To Struggle As Competition Increases
  • Is Starbucks Shooting For The Moon?
  • Two High-Yield Deep-Values You Shouldn't Ignore

Receive News & Ratings for BetterLife Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BetterLife Pharma and related companies with's FREE daily email newsletter.

Risk disclosure: The above content only represents the opinion of the authors or guests, and does not represent any positions of Futu or constitute any investment advice on the part of Futu. Before making any investment decision, investors should consider the risk factors related to investment products based on their own circumstances and consult professional investment advisers where necessary. Futu makes every effort to verify the authenticity, accuracy, and originality of the above content, but does not make any guarantees or promises.

Back to the Top